Nitric oxide homeostasis as a target for drug additives to cardioplegia
about
Anticoagulant action of low, physiologic, and high albumin levels in whole blood.Limitation of myocardial and endothelial injury of the rat heart graft after preservation with Centre de Résonance Magnétique Biologique et Médicale (CRMB) solution.The nitric oxide donor, S-nitroso human serum albumin, as an adjunct to HTK-N cardioplegia improves protection during cardioplegic arrest after myocardial infarction in rats.Enhanced preservation of pig cardiac allografts by combining erythropoietin with glyceryl trinitrate and zoniporide.β₂-Glycoprotein I inhibits endothelial cell migration through the nuclear factor κB signalling pathway and endothelial nitric oxide synthase activation.
P2860
Nitric oxide homeostasis as a target for drug additives to cardioplegia
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Nitric oxide homeostasis as a target for drug additives to cardioplegia
@ast
Nitric oxide homeostasis as a target for drug additives to cardioplegia
@en
type
label
Nitric oxide homeostasis as a target for drug additives to cardioplegia
@ast
Nitric oxide homeostasis as a target for drug additives to cardioplegia
@en
prefLabel
Nitric oxide homeostasis as a target for drug additives to cardioplegia
@ast
Nitric oxide homeostasis as a target for drug additives to cardioplegia
@en
P2860
P356
P1476
Nitric oxide homeostasis as a target for drug additives to cardioplegia
@en
P2093
B K Podesser
S Hallström
P2860
P304
P356
10.1038/SJ.BJP.0707272
P407
P577
2007-05-08T00:00:00Z